tradingkey.logo
tradingkey.logo
Search

OS Therapies Inc

OSTX
Add to Watchlist
1.520USD
0.0000.00%
Close 07-27 16:00ETQuotes delayed by 15 min
69.67MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Einodmil LLC
6.31%
Romness (Paul A.)
5.88%
Ayala Pharmaceuticals Inc
5.15%
Satterfield (Thomas A Jr)
4.18%
Vanguard Capital Management, LLC
1.12%
Other
77.36%
Shareholders
Shareholders
Proportion
Einodmil LLC
6.31%
Romness (Paul A.)
5.88%
Ayala Pharmaceuticals Inc
5.15%
Satterfield (Thomas A Jr)
4.18%
Vanguard Capital Management, LLC
1.12%
Other
77.36%
Shareholder Types
Shareholders
Proportion
Individual Investor
11.99%
Corporation
11.46%
Investment Advisor
4.23%
Investment Advisor/Hedge Fund
1.29%
Hedge Fund
0.28%
Research Firm
0.09%
Other
70.66%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
41
2.99M
7.12%
+1.31M
2025Q4
30
1.91M
5.44%
+1.08M
2025Q3
22
957.53K
2.86%
+502.43K
2025Q2
23
9.77M
34.77%
+2.15M
2025Q1
22
7.75M
30.50%
+442.25K
2024Q4
17
4.66M
21.86%
+177.62K
2024Q3
14
5.14M
25.63%
+5.14M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Einodmil LLC
2.65M
7.54%
-10.00K
-0.38%
Jul 29, 2025
Romness (Paul A.)
2.47M
7.02%
--
--
Aug 20, 2025
Ayala Pharmaceuticals Inc
2.16M
6.15%
+2.16M
--
Apr 09, 2025
Satterfield (Thomas A Jr)
1.76M
4.99%
+751.34K
+74.76%
Jun 30, 2025
CM Management, LLC
400.00K
1.14%
+25.00K
+6.67%
Sep 30, 2025
Geode Capital Management, L.L.C.
187.69K
0.53%
+187.69K
--
Sep 30, 2025
Search (Theodore F. Pharm.D.)
237.92K
0.68%
--
--
Aug 20, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proportion0.01%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.